On Friday, Guardant Health Inc (NASDAQ: GH) opened higher 0.10% from the last session, before settling in for the closing price of $41.68. Price fluctuations for GH have ranged from $18.01 to $52.92 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 28.17% over the past five years. Company’s average yearly earnings per share was noted 22.03% at the time writing. With a float of $117.60 million, this company’s outstanding shares have now reached $123.65 million.
Let’s look at the performance matrix of the company that is accounted for 2021 employees. In terms of profitability, gross margin is 61.34%, operating margin of -58.78%, and the pretax margin is -53.67%.
Guardant Health Inc (GH) Insider Updates
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Guardant Health Inc is 5.07%, while institutional ownership is 96.56%. The most recent insider transaction that took place on May 01 ’25, was worth 5,233,421. In this transaction Co-Chief Executive Officer of this company sold 106,784 shares at a rate of $49.01, taking the stock ownership to the 2,202,672 shares. Before that another transaction happened on May 02 ’25, when Company’s Co-Chief Executive Officer sold 13,932 for $50.47, making the entire transaction worth $703,151. This insider now owns 2,188,740 shares in total.
Guardant Health Inc (GH) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 22.03% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.66% during the next five years compared to -33.61% drop over the previous five years of trading.
Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators
Check out the current performance indicators for Guardant Health Inc (GH). In the past quarter, the stock posted a quick ratio of 3.76. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.38, a number that is poised to hit -0.72 in the next quarter and is forecasted to reach -2.39 in one year’s time.
Technical Analysis of Guardant Health Inc (GH)
Guardant Health Inc (NASDAQ: GH) saw its 5-day average volume 3.62 million, a positive change from its year-to-date volume of 2.43 million. As of the previous 9 days, the stock’s Stochastic %D was 15.55%. Additionally, its Average True Range was 3.13.
During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 51.33%, which indicates a significant increase from 20.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 62.69% in the past 14 days, which was lower than the 72.78% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $43.64, while its 200-day Moving Average is $34.77. Nevertheless, the first resistance level for the watch stands at $42.86 in the near term. At $44.00, the stock is likely to face the second major resistance level. The third major resistance level sits at $44.88. If the price goes on to break the first support level at $40.84, it is likely to go to the next support level at $39.96. Assuming the price breaks the second support level, the third support level stands at $38.82.
Guardant Health Inc (NASDAQ: GH) Key Stats
There are currently 123,888K shares outstanding in the company with a market cap of 5.17 billion. Presently, the company’s annual sales total 739,020 K according to its annual income of -436,370 K. Last quarter, the company’s sales amounted to 203,470 K and its income totaled -95,160 K.
